Fortress Biotech, Inc. (FBIOP) Net income 2016–2025
Fortress Biotech, Inc. (FBIOP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$6.8MFY2025 · since FY2016: -$55.1M → $6.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.8M | +114.8% |
| FY2024 | -$46.0M | +24.1% |
| FY2023 | -$60.6M | +30.0% |
| FY2022 | -$86.6M | -33.8% |
| FY2021 | -$64.7M | -39.1% |
| FY2020 | -$46.5M | -16.4% |
| FY2019 | -$40.0M | +52.5% |
| FY2018 | -$84.1M | -25.8% |
| FY2017 | -$66.9M | -21.4% |
| FY2016 | -$55.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBIOP financial trends
FBIOP RevenueFBIOP Net marginFBIOP Gross profitFBIOP Gross marginFBIOP Operating incomeFBIOP Operating marginFBIOP Operating cash flowFBIOP Free cash flowFBIOP Capital expendituresFBIOP Return on equityFBIOP Stock buybacksFBIOP Dividends paidFBIOP Total assetsFBIOP Total liabilitiesFBIOP Shareholders’ equityFBIOP overview →